These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

472 related articles for article (PubMed ID: 25350971)

  • 1. The ubiquitin E3 ligase ITCH enhances breast tumor progression by inhibiting the Hippo tumor suppressor pathway.
    Salah Z; Itzhaki E; Aqeilan RI
    Oncotarget; 2014 Nov; 5(21):10886-900. PubMed ID: 25350971
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Negative regulation of the Hippo pathway by E3 ubiquitin ligase ITCH is sufficient to promote tumorigenicity.
    Salah Z; Melino G; Aqeilan RI
    Cancer Res; 2011 Mar; 71(5):2010-20. PubMed ID: 21212414
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RARγ Downregulation Contributes to Colorectal Tumorigenesis and Metastasis by Derepressing the Hippo-Yap Pathway.
    Guo PD; Lu XX; Gan WJ; Li XM; He XS; Zhang S; Ji QH; Zhou F; Cao Y; Wang JR; Li JM; Wu H
    Cancer Res; 2016 Jul; 76(13):3813-25. PubMed ID: 27325643
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum deprivation inhibits the transcriptional co-activator YAP and cell growth via phosphorylation of the 130-kDa isoform of Angiomotin by the LATS1/2 protein kinases.
    Adler JJ; Johnson DE; Heller BL; Bringman LR; Ranahan WP; Conwell MD; Sun Y; Hudmon A; Wells CD
    Proc Natl Acad Sci U S A; 2013 Oct; 110(43):17368-73. PubMed ID: 24101513
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Src Inhibits the Hippo Tumor Suppressor Pathway through Tyrosine Phosphorylation of Lats1.
    Si Y; Ji X; Cao X; Dai X; Xu L; Zhao H; Guo X; Yan H; Zhang H; Zhu C; Zhou Q; Tang M; Xia Z; Li L; Cong YS; Ye S; Liang T; Feng XH; Zhao B
    Cancer Res; 2017 Sep; 77(18):4868-4880. PubMed ID: 28754671
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cell growth density modulates cancer cell vascular invasion via Hippo pathway activity and CXCR2 signaling.
    Sharif GM; Schmidt MO; Yi C; Hu Z; Haddad BR; Glasgow E; Riegel AT; Wellstein A
    Oncogene; 2015 Nov; 34(48):5879-89. PubMed ID: 25772246
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deubiquitinase YOD1: the potent activator of YAP in hepatomegaly and liver cancer.
    Kim Y; Jho EH
    BMB Rep; 2017 Jun; 50(6):281-282. PubMed ID: 28502290
    [TBL] [Abstract][Full Text] [Related]  

  • 8. KIBRA exhibits MST-independent functional regulation of the Hippo signaling pathway in mammals.
    Moleirinho S; Chang N; Sims AH; Tilston-Lünel AM; Angus L; Steele A; Boswell V; Barnett SC; Ormandy C; Faratian D; Gunn-Moore FJ; Reynolds PA
    Oncogene; 2013 Apr; 32(14):1821-30. PubMed ID: 22614006
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Itch E3 ubiquitin ligase regulates large tumor suppressor 1 stability [corrected].
    Ho KC; Zhou Z; She YM; Chun A; Cyr TD; Yang X
    Proc Natl Acad Sci U S A; 2011 Mar; 108(12):4870-5. PubMed ID: 21383157
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TGF-β Targets the Hippo Pathway Scaffold RASSF1A to Facilitate YAP/SMAD2 Nuclear Translocation.
    Pefani DE; Pankova D; Abraham AG; Grawenda AM; Vlahov N; Scrace S; O' Neill E
    Mol Cell; 2016 Jul; 63(1):156-66. PubMed ID: 27292796
    [TBL] [Abstract][Full Text] [Related]  

  • 11. BRCA1/BARD1-dependent ubiquitination of NF2 regulates Hippo-YAP1 signaling.
    Verma S; Yeddula N; Soda Y; Zhu Q; Pao G; Moresco J; Diedrich JK; Hong A; Plouffe S; Moroishi T; Guan KL; Verma IM
    Proc Natl Acad Sci U S A; 2019 Apr; 116(15):7363-7370. PubMed ID: 30918126
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of Hippo/YAP signaling and Esophageal Squamous Carcinoma progression by an E3 ubiquitin ligase PARK2.
    Zhou X; Li Y; Wang W; Wang S; Hou J; Zhang A; Lv B; Gao C; Yan Z; Pang D; Lu K; Ahmad NH; Wang L; Zhu J; Zhang L; Zhuang T; Li X
    Theranostics; 2020; 10(21):9443-9457. PubMed ID: 32863938
    [No Abstract]   [Full Text] [Related]  

  • 13. hRAD9 functions as a tumor suppressor by inducing p21-dependent senescence and suppressing epithelial-mesenchymal transition through inhibition of Slug transcription.
    Wen FC; Chang TW; Tseng YL; Lee JC; Chang MC
    Carcinogenesis; 2014 Jul; 35(7):1481-90. PubMed ID: 24403312
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deubiquitinating Enzyme USP9X Suppresses Tumor Growth via LATS Kinase and Core Components of the Hippo Pathway.
    Toloczko A; Guo F; Yuen HF; Wen Q; Wood SA; Ong YS; Chan PY; Shaik AA; Gunaratne J; Dunne MJ; Hong W; Chan SW
    Cancer Res; 2017 Sep; 77(18):4921-4933. PubMed ID: 28720576
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The E3 ubiquitin ligase Itch and Yap1 have antagonistic roles in the regulation of ASPP2 protein stability.
    Gao K; An J; Zhang Y; Jin X; Ma J; Peng J; Tang Y; Yu L; Zhang P; Wang C
    FEBS Lett; 2015 Jan; 589(1):94-101. PubMed ID: 25436413
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Ca
    Dang DK; Makena MR; Llongueras JP; Prasad H; Ko M; Bandral M; Rao R
    Mol Cancer Res; 2019 Aug; 17(8):1735-1747. PubMed ID: 31076498
    [TBL] [Abstract][Full Text] [Related]  

  • 17. YAP promotes breast cell proliferation and survival partially through stabilizing the KLF5 transcription factor.
    Zhi X; Zhao D; Zhou Z; Liu R; Chen C
    Am J Pathol; 2012 Jun; 180(6):2452-61. PubMed ID: 22632819
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The E3 ubiquitin ligase ITCH negatively regulates canonical Wnt signaling by targeting dishevelled protein.
    Wei W; Li M; Wang J; Nie F; Li L
    Mol Cell Biol; 2012 Oct; 32(19):3903-12. PubMed ID: 22826439
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CRABP2 regulates invasion and metastasis of breast cancer through hippo pathway dependent on ER status.
    Feng X; Zhang M; Wang B; Zhou C; Mu Y; Li J; Liu X; Wang Y; Song Z; Liu P
    J Exp Clin Cancer Res; 2019 Aug; 38(1):361. PubMed ID: 31419991
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypoxia regulates Hippo signalling through the SIAH2 ubiquitin E3 ligase.
    Ma B; Chen Y; Chen L; Cheng H; Mu C; Li J; Gao R; Zhou C; Cao L; Liu J; Zhu Y; Chen Q; Wu S
    Nat Cell Biol; 2015 Jan; 17(1):95-103. PubMed ID: 25438054
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.